FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057058781> ?p ?o ?g. }

• W2057058781 endingPage "2402" @default.
• W2057058781 startingPage "2396" @default.
• W2057058781 abstract "Myelosuppression occurs in up to 50% of patients with chronic myeloid leukemia (CML) who are treated with imatinib and > or = Grade 3 myelosuppression is reported in approximately 10% of patients.The authors investigated the prognostic significance of anemia occurring during therapy with imatinib in patients with CML in chronic phase.Of 338 patients treated with imatinib (150 patients after interferon failure and 188 patients with newly diagnosed CML), 230 (68%) developed anemia. In a multivariate analysis, factors associated with an increased probability of developing anemia were a starting hemoglobin level < 12 g/dL, age > or = 60 years, female gender, higher imatinib dose, and intermediate or high Sokal risk group. Of these 230 patients, 102 patients received treatment with 40,000 U of recombinant human erythropoietin administered subcutaneously once weekly. An increase in the hemoglobin level of > or = 2 g/dL was achieved in 69 patients (68%) and 22 patients (22%) had an increase of 1-1.9 g/dL. Patients who developed anemia had a trend toward a lower probability of complete cytogenetic remission compared with patients without anemia (68% vs. 77%; P = 0.14), as well as a trend for inferior survival. Patients with anemia and other manifestations of myelosuppression were found to have a significantly worse outcome than those with isolated anemia.The authors concluded that erythropoietin is safe and effective in patients in chronic-phase CML who develop anemia with imatinib therapy." @default.
• W2057058781 created "2016-06-24" @default.
• W2057058781 creator A5004793038 @default.
• W2057058781 creator A5006104041 @default.
• W2057058781 creator A5011529063 @default.
• W2057058781 creator A5015140142 @default.
• W2057058781 creator A5028070547 @default.
• W2057058781 creator A5059555096 @default.
• W2057058781 creator A5061285204 @default.
• W2057058781 creator A5090435894 @default.
• W2057058781 date "2004-01-01" @default.
• W2057058781 modified "2023-10-12" @default.
• W2057058781 title "Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase" @default.
• W2057058781 cites W1531963607 @default.
• W2057058781 cites W1963871766 @default.
• W2057058781 cites W1992838550 @default.
• W2057058781 cites W2004089260 @default.
• W2057058781 cites W2011474502 @default.
• W2057058781 cites W2013850642 @default.
• W2057058781 cites W2016086822 @default.
• W2057058781 cites W2028959752 @default.
• W2057058781 cites W2041655620 @default.
• W2057058781 cites W2069710741 @default.
• W2057058781 cites W2091653492 @default.
• W2057058781 cites W2097255369 @default.
• W2057058781 cites W2112833469 @default.
• W2057058781 cites W2142969636 @default.
• W2057058781 cites W2171722798 @default.
• W2057058781 cites W2288973879 @default.
• W2057058781 cites W2312804644 @default.
• W2057058781 cites W2329648702 @default.
• W2057058781 cites W2438125759 @default.
• W2057058781 cites W27031567 @default.
• W2057058781 cites W4293241248 @default.
• W2057058781 doi "https://doi.org/10.1002/cncr.20292" @default.
• W2057058781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15160343" @default.
• W2057058781 hasPublicationYear "2004" @default.
• W2057058781 type Work @default.
• W2057058781 sameAs 2057058781 @default.
• W2057058781 citedByCount "36" @default.
• W2057058781 countsByYear W20570587812012 @default.
• W2057058781 countsByYear W20570587812013 @default.
• W2057058781 countsByYear W20570587812014 @default.
• W2057058781 countsByYear W20570587812015 @default.
• W2057058781 countsByYear W20570587812016 @default.
• W2057058781 countsByYear W20570587812019 @default.
• W2057058781 countsByYear W20570587812020 @default.
• W2057058781 countsByYear W20570587812021 @default.
• W2057058781 countsByYear W20570587812022 @default.
• W2057058781 countsByYear W20570587812023 @default.
• W2057058781 crossrefType "journal-article" @default.
• W2057058781 hasAuthorship W2057058781A5004793038 @default.
• W2057058781 hasAuthorship W2057058781A5006104041 @default.
• W2057058781 hasAuthorship W2057058781A5011529063 @default.
• W2057058781 hasAuthorship W2057058781A5015140142 @default.
• W2057058781 hasAuthorship W2057058781A5028070547 @default.
• W2057058781 hasAuthorship W2057058781A5059555096 @default.
• W2057058781 hasAuthorship W2057058781A5061285204 @default.
• W2057058781 hasAuthorship W2057058781A5090435894 @default.
• W2057058781 hasBestOaLocation W20570587811 @default.
• W2057058781 hasConcept C126322002 @default.
• W2057058781 hasConcept C2775989426 @default.
• W2057058781 hasConcept C2776960273 @default.
• W2057058781 hasConcept C2777417653 @default.
• W2057058781 hasConcept C2777583451 @default.
• W2057058781 hasConcept C2778248108 @default.
• W2057058781 hasConcept C2778461978 @default.
• W2057058781 hasConcept C2778534260 @default.
• W2057058781 hasConcept C2778729363 @default.
• W2057058781 hasConcept C2778917026 @default.
• W2057058781 hasConcept C3019892230 @default.
• W2057058781 hasConcept C71924100 @default.
• W2057058781 hasConcept C90924648 @default.
• W2057058781 hasConceptScore W2057058781C126322002 @default.
• W2057058781 hasConceptScore W2057058781C2775989426 @default.
• W2057058781 hasConceptScore W2057058781C2776960273 @default.
• W2057058781 hasConceptScore W2057058781C2777417653 @default.
• W2057058781 hasConceptScore W2057058781C2777583451 @default.
• W2057058781 hasConceptScore W2057058781C2778248108 @default.
• W2057058781 hasConceptScore W2057058781C2778461978 @default.
• W2057058781 hasConceptScore W2057058781C2778534260 @default.
• W2057058781 hasConceptScore W2057058781C2778729363 @default.
• W2057058781 hasConceptScore W2057058781C2778917026 @default.
• W2057058781 hasConceptScore W2057058781C3019892230 @default.
• W2057058781 hasConceptScore W2057058781C71924100 @default.
• W2057058781 hasConceptScore W2057058781C90924648 @default.
• W2057058781 hasIssue "11" @default.
• W2057058781 hasLocation W20570587811 @default.
• W2057058781 hasLocation W20570587812 @default.
• W2057058781 hasOpenAccess W2057058781 @default.
• W2057058781 hasPrimaryLocation W20570587811 @default.
• W2057058781 hasRelatedWork W1984313504 @default.
• W2057058781 hasRelatedWork W1988956304 @default.
• W2057058781 hasRelatedWork W2054377045 @default.
• W2057058781 hasRelatedWork W2070391470 @default.
• W2057058781 hasRelatedWork W2093487133 @default.
• W2057058781 hasRelatedWork W2264704452 @default.
• W2057058781 hasRelatedWork W2309630174 @default.

• next